Mingxuan Chen,Yongheng An,Hongsheng Yu,Yifan Li,Xiaoman Chen. Damage of Wistar rats liver after using hypo-fractionated radiation and oxaliplation. Oncol Transl Med, 2015, 1: 130-134.
Damage of Wistar rats liver after using hypo-fractionated radiation and oxaliplation
Received:February 08, 2015  Revised:June 02, 2015
View Full Text  View/Add Comment  Download reader
KeyWord:radiation effects; concurrent chemoradiotherapy; rat liver; Bcl-2; Bax
Author NameAffiliationE-mail
Mingxuan Chen Department of Oncology,The Affiliated Hospital of Qingdao University,Qingdao,Shandong chenmingxuancc@sina.com 
Yongheng An Department of Oncology,The Affiliated Hospital of Qingdao University,Qingdao,Shandong anyongheng@126.com 
Hongsheng Yu Department of Oncology,The Affiliated Hospital of Qingdao University,Qingdao,Shandong qdhsyu@163.com 
Yifan Li Department of Breast Center,The Affiliated Hospital of Qingdao University,Qingdao,Shandong 21729860@163.com 
Xiaoman Chen Department of Oncology,The Affiliated Hospital of Qingdao University,Qingdao,Shandong 465146825@qq.com 
Hits: 6533
Download times: 7490
Abstract:
      Objective The purpose of this study was to clarify whether hypo-fractionated radiation therapy combined with oxaliplatin can aggravate liver damage, in order to determine its safety for clinical application. Methods Eighty Wistar rats were randomly divided into four groups: the control group, the chemotherapy treatment group, the radiation treatment group, and the concurrent chemoradiotherapy group. The rats’ liver tissues were then collected for histological evaluation at the first, second, fourth, sixth, and eight week after irradiation. The tissues were histologically evaluated using hematoxylin and eosin staining, and immunohistochemistry to analyze the expression of Bcl-2 and Bax. Results Histological examination revealed swollen hepatocellular cells in the experimental groups, with visible liver degeneration and necrosis. Alanine aminotransferase and aspartate aminotransferase levels were significantly different between the groups (F = 85.869 and 214.663; P < 0.001). The intra-group expressions of Bcl-2 and Bax were also significantly different between each time point (F = 6.047 and 43.344; P < 0.05). Bax expression was significantly different between each group (F = 8.122; P < 0.05), although no inter-group differences were observed for Bcl-2 expression (F = 0.808; P > 0.05). Conclusion Chemoradiotherapy may aggravate liver injury, possible via overexpression of Bcl-2 and reduced expression of Bax. Therefore, this treatment should be used carefully in the clinic.
Close